Countries in developing

Per capita use of water in developed countries is about 10 times greater than in developing countries. In developed countries this estimate varies between 500L/da and 800L/da, and in developing countries from 60L/da to 150L/da. 

Nephrotic patients (especially children) are prone to bacterial infections. Before antibiotics and corticosteroids were introduced into the therapy, pneumonia, peritonitis, and sepsis (usually caused by pneumococci) were the most frequent cause of death of nephrotic children with minimal change disease. Infections are more frequent in nephrotic children and after the age of 20 their prevalence markedly decreases because the majority of adults have antibodies against the capsular antigens of pneumococci. Infections remain an important complication of nephrotic syndrome in developing countries. In developed countries, nephrotic patients treated by immunosuppressive agents may frequently suffer from viral infections (mainly herpesvirus infections, e.g., cytomegalovirus and Epstein-Barr virus infections). 

This book deals with the history of the discovery of chemical elements from ancient times to the present day. In the course of writing this history, the authors relate the most important regularities in the process of discovery of elements, the role of various methods of study they throw light upon the contribution of scientists from different countries in developing the science about elements. This book is a supplement to school text-books of chemistry and could be valuable to pupils in their independent studies. 

Reed, T. B. and Larson, R., A wood-Gas Stove for Developing Countries, in Developments in Thermochemical Biomass Conversion, Ed. A. V. Bridgwater, Blackie Academic Press, 1996. 

Viruses have been implicated in the development of at least two cancers. Infection with the human papilloma virus is a major risk factor for cervical cancer, and like any sexually transmitted disease, the cancer is more common amongst those who have had numerous partners and is almost unknown in nuns. But the most well-established link is between Burkitt s lymphoma and the Epstein-Barr virus (one of the herpes viruses) in African countries. In developed countries, this virus causes glandular fever (infectious mononucleosis), and the different progress of the disease in Africans is apparently due to an immune system that is usually suppressed through a long-term assault by malaria parasites like Plasmodium falciparum. 

Theophylline, a methylxanthine, still is commonly used for asthma pharmacotherapy in many countries. In developed countries, the advent of inhaled glucocorticoids, fi adrenergic receptor agonists, and leukotriene-modifying drugs has diminished theophylhne use significantly, and it has been relegated to a third- or fourth-line treatment in patients whose asthma is otherwise difficult to control. 

Comprehensive, large-scale evaluations may include a cost-benefit analysis however, this type of analysis is frequently omitted in smaller evaluations where evaluators lack access to resources or to adequate data, and is more common in developed than in developing countries. In developing countries, full cost-benefit analyses have rarely been undertaken. For a good example of full cost-benefit analysis, see Coady (2000) on Mexico s PROGRESA and Econo-metria Consultores, Institute for Fiscal Studies and Sistemas Especializados de Informacion (2006) on Colombia s Familias en Accion. 

Dietary recommendations for infants are based on the iron content and bioavailability of human milk. The iron in infant formula is much less bioavailable (10%) than that of human milk and is thus present in greater concentrations than that of human milk. Infants who are not breast-fed should consume iron-fortified formula. Complementary foods offered after 6 months of age can potentially meet iron needs if they have a high content of meat and ascorbic acid. This is rarely the case in developing or developed countries, and fortified infant cereals and iron drops are often introduced at this time in developed countries. In developing countries where diets are poor in bioavailable iron, iron-fortified weaning foods are not commonly consumed, and iron supplements are rarely given to infants and children. 

The need for redundancy in the culture system needs to be assessed. Failure of a well pump that brings up water to supply a static pond system may not be a serious problem in countries where new pumps can be purchased in a nearby town. However, it can be disastrous in developing countries where new pumps and pump parts are often not available, but must be ordered from another country. Several weeks or months may pass before the situation can be remedied unless the culturist maintains a selection of spares. 

Worldwide furfuryl alcohol capacity in 1993 was estimated to be 110,000 metric tons (38). As with furfural, new capacity in developing countries is replacing older capacity in developed countries. China and South Africa have become significant producers of furfuryl alcohol. New plants have been built in Asia and Indonesia as well. Consumption of furfuryl alcohol is spread over the globe the largest use is in the foundry industry which is increasingly moving away from heavily industrialized countries. 

Several countries have developed their own standard test methods for cellular plastics, and the International Organization for Standards (ISO) Technical Committee on Plastics TC-61 has been developing international standards. Information concerning the test methods for any particular country or the ISO procedures can be obtained in the United States from the American National Standards Institute. The most complete set of test procedures for cellular plastics, and the most used of any in the world, is that developed by the ASTM these procedures are pubUshed in new editions each year (128). There have been several reviews of ASTM methods and others pertinent to cellular plastics (32,59,129—131). 

Full details of this work were pubHshed (6) and the processes, or variants of them, were introduced in a number of other countries. In the United States, the pharmaceutical industry continued to provide manufacturing sites, treating plasma fractionation as a normal commercial activity. In many other countries processing was undertaken by the Red Cross or blood transfusion services that emerged following Wodd War II. In these organisations plasma fractionation was part of a larger operation to provide whole blood, blood components, and speciaUst medical services on a national basis. These different approaches resulted in the development of two distinct sectors in the plasma fractionation industry ie, a commercial or for-profit sector based on paid donors and a noncommercial or not-for-profit sector based on unpaid donors. 

C. Otte, Geothermal Energy in Developing Countries, Energy and the Environment in the 21st Century, MIT Press, Cambridge, Mass., 1991, p. 755. 

Total merchant shipments of DRI and HBI in 1993 reached 5.1 x 10 t. The primary DRI exporting countries were Venezuela, Russia, Malaysia, Trinidad, and India. The price of merchant HBI in 1993 was in the range of 125 to 167/1 on a deUvered basis. Although there are expectations that the value of merchant DRI should some day stand on its own, the historic price has been tied to the price of ferrous scrap. A general mle of thumb has been that the value of merchant DRI is comparable to prime scrap (No. 1 Bundles or No. 1 Bushelings) in industrial countries, and comparable to imported shredded scrap in developing countries (see RECYCLING, FERROUS METALS). 

Butter, fresh and salted, was once a primary trade commodity, but is no longer in as high a demand. There has been a shift in emphasis from fat content to the protein, mineral, and vitamin content of milk and milk products, particularly in developed countries. 

Unlike the common practice occurring in other countries, in which award of patent rights is based on the date on which a patent apphcation is filed, in the United States the patent grant is based on the first date of invention. To be an inventor in the United States, an individual must contribute to conception of the invention, and may contribute to reduction of the invention to practice. Although the creation of an advance, development, or apphcation may be conceived by one given individual, it often is the case that the act of invention is the work of many individuals, especially in a commercial context. Accordingly, inventorship questions often arise. 

At least three types of citations in patents can be identified inventors citations found in the patent specification, examiners citations found on issued U.S. patents, and examiners citations found on pubHshed appHcations and granted patents from other countries. A patent inventor cites prior art in order to distance the invention from that art, rather than to show a close relationship. Whereas scientific researchers may want to show how closely they have built on what went before, for an inventor that can suggest anticipation or at least obviousness. Thus, citations within a patent typicaHy try to demonstrate the inadequacies of prior inventions and the uniqueness of the patentee s own work. References tied by this type of citation can be usefiil in developing a picture of the state of the art, but often show sharply differing technologies. 

---